QIAGEN develops Sample to Insight kits, instruments, assays and bioinformatics for molecular diagnostics, research, applied testing, forensics and food safety.
QIAGEN, founded in 1984, develops Sample to Insight solutions that help customers extract and interpret information from biological samples. The offering spans sample preparation and testing kits, laboratory instruments, assays and bioinformatics, assembled into end-to-end workflows used by more than 500,000 customers worldwide. The company operates globally.
Its technical work covers molecular diagnostics, sample preparation, assay development, instrument development, bioinformatics and life science and clinical research. These capabilities are applied across molecular diagnostics, clinical research, life science research, pharmaceutical research, applied testing, forensics and food safety, as well as healthcare more broadly.
QIAGEN employs about 5,700 people, with more than 75 nationalities represented in its workforce. Work is organised across R&D, customer-facing teams, finance, HR and production, with an emphasis on cross-functional collaboration and on ideas being welcomed from every level.
The company states three guiding principles: Quality, Ingenuity and Accessibility. It describes its culture as collaborative and inclusive, with respect for diverse perspectives and scope for employees to continue developing, oriented around advancing science and improving healthcare.
